{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,21]],"date-time":"2026-02-21T02:26:17Z","timestamp":1771640777345,"version":"3.50.1"},"reference-count":59,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100014718","name":"Innovative Research Group Project of the National Natural Science Foundation of China","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100014718","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100017287","name":"Special Funds for the Basic Research and Development Program in the Central Non-profit Research Institutes of China","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100017287","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biomaterials"],"published-print":{"date-parts":[[2023,1]]},"DOI":"10.1016\/j.biomaterials.2022.121936","type":"journal-article","created":{"date-parts":[[2022,11,30]],"date-time":"2022-11-30T05:29:19Z","timestamp":1669786159000},"page":"121936","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":30,"special_numbering":"C","title":["A nanoformulation for immunosuppression reversal and broad-spectrum self-amplifying antitumor ferroptosis-immunotherapy"],"prefix":"10.1016","volume":"292","author":[{"given":"Qunfang","family":"Yang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tao","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Haiping","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zechen","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yan","family":"Huang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Honglin","family":"Jia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shixiang","family":"Fu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xuan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Haigang","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ya","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaohong","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5983-8455","authenticated-orcid":false,"given":"Wenjun","family":"Shan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.biomaterials.2022.121936_bib1","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.immuni.2019.12.018","article-title":"Tumor immunology and tumor evolution: intertwined histories","volume":"52","author":"Galon","year":"2020","journal-title":"Immunity"},{"key":"10.1016\/j.biomaterials.2022.121936_bib2","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1038\/s41568-021-00339-z","article-title":"Antigen presentation in cancer: insights into tumour immunogenicity and immune evasion","volume":"21","author":"Jhunjhunwala","year":"2021","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.biomaterials.2022.121936_bib3","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1002\/cac2.12250","article-title":"Ferroptosis in cancer and cancer immunotherapy","volume":"42","author":"Zhao","year":"2022","journal-title":"Cancer Commun."},{"key":"10.1016\/j.biomaterials.2022.121936_bib4","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1038\/s41577-020-0306-5","article-title":"A guide to cancer immunotherapy: from T cell basic science to clinical practice","volume":"20","author":"Waldman","year":"2020","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.biomaterials.2022.121936_bib5","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1016\/j.ccell.2015.03.007","article-title":"The journey from discoveries in fundamental immunology to cancer immunotherapy","volume":"27","author":"Miller","year":"2015","journal-title":"Cancer Cell"},{"key":"10.1016\/j.biomaterials.2022.121936_bib6","doi-asserted-by":"crossref","first-page":"12680","DOI":"10.1002\/anie.201906288","article-title":"Organic semiconducting pro\u2010nanostimulants for near\u2010infrared photoactivatable cancer immunotherapy","volume":"58","author":"Li","year":"2019","journal-title":"Angew. Chem. Int. Ed."},{"key":"10.1016\/j.biomaterials.2022.121936_bib7","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1186\/s13045-019-0804-8","article-title":"Tumor-intrinsic signaling pathways: key roles in the regulation of the immunosuppressive tumor microenvironment","volume":"12","author":"Yang","year":"2019","journal-title":"J. Hematol. Oncol.J Hematol Oncol."},{"key":"10.1016\/j.biomaterials.2022.121936_bib8","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1038\/s41568-019-0149-1","article-title":"Ferroptosis at the crossroads of cancer-acquired drug resistance and immune evasion","volume":"19","author":"Friedmann Angeli","year":"2019","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.biomaterials.2022.121936_bib9","article-title":"Ferroptosis: an iron-dependent form of nonapoptotic cell death","volume":"149","author":"Sj","year":"2012","journal-title":"Cell"},{"key":"10.1016\/j.biomaterials.2022.121936_bib10","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2020-001369","article-title":"Vaccination with early ferroptotic cancer cells induces efficient antitumor immunity","volume":"8","author":"Efimova","year":"2020","journal-title":"J. Immunother. Cancer."},{"key":"10.1016\/j.biomaterials.2022.121936_bib11","doi-asserted-by":"crossref","DOI":"10.1080\/2162402X.2020.1862949","article-title":"Ferroptosis becomes immunogenic: implications for anticancer treatments","volume":"10","author":"Tang","year":"2021","journal-title":"OncoImmunology"},{"key":"10.1016\/j.biomaterials.2022.121936_bib12","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1038\/s41586-019-1170-y","article-title":"CD8+ T cells regulate tumour ferroptosis during cancer immunotherapy","volume":"569","author":"Wang","year":"2019","journal-title":"Nature"},{"key":"10.1016\/j.biomaterials.2022.121936_bib13","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1038\/nature23007","article-title":"Dependency of a therapy-resistant state of cancer cells on a lipid peroxidase pathway","volume":"547","author":"Viswanathan","year":"2017","journal-title":"Nature"},{"key":"10.1016\/j.biomaterials.2022.121936_bib14","doi-asserted-by":"crossref","first-page":"31189","DOI":"10.1073\/pnas.2017152117","article-title":"Oncogenic activation of PI3K-AKT-mTOR signaling suppresses ferroptosis via SREBP-mediated lipogenesis","volume":"117","author":"Yi","year":"2020","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.biomaterials.2022.121936_bib15","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2021-003430","article-title":"Immunogenic ferroptosis and where to find it?","volume":"9","author":"Demuynck","year":"2021","journal-title":"J. Immunother. Cancer."},{"key":"10.1016\/j.biomaterials.2022.121936_bib16","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1016\/j.cell.2011.02.013","article-title":"Hallmarks of cancer: the next generation","volume":"144","author":"Hanahan","year":"2011","journal-title":"Cell"},{"key":"10.1016\/j.biomaterials.2022.121936_bib17","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1158\/2159-8290.CD-13-0458","article-title":"Immune cell-poor melanomas benefit from PD-1 blockade after targeted type I IFN activation","volume":"4","author":"Bald","year":"2014","journal-title":"Cancer Discov."},{"key":"10.1016\/j.biomaterials.2022.121936_bib18","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1016\/j.celrep.2017.04.031","article-title":"Interferon receptor signaling pathways regulating PD-L1 and PD-L2 expression","volume":"19","author":"Garcia-Diaz","year":"2017","journal-title":"Cell Rep."},{"key":"10.1016\/j.biomaterials.2022.121936_bib19","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1016\/j.cell.2019.07.019","article-title":"Opposing functions of interferon coordinate adaptive and innate immune responses to cancer immune checkpoint blockade","volume":"178","author":"Benci","year":"2019","journal-title":"Cell"},{"key":"10.1016\/j.biomaterials.2022.121936_bib20","first-page":"15","article-title":"Semiconducting polymer nanoparticles with surface\u2010mimicking protein secondary structure as lysosome\u2010targeting chimaeras for self\u2010synergistic cancer immunotherapy","author":"Qi","year":"2022","journal-title":"Adv. Mater."},{"key":"10.1016\/j.biomaterials.2022.121936_bib21","doi-asserted-by":"crossref","DOI":"10.1016\/j.biomaterials.2021.121103","article-title":"Multifaceted roles of a bioengineered nanoreactor in repressing radiation-induced lung injury","volume":"277","author":"Liu","year":"2021","journal-title":"Biomaterials"},{"key":"10.1016\/j.biomaterials.2022.121936_bib22","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1038\/s41467-021-20904-2","article-title":"NUPR1 is a critical repressor of ferroptosis","volume":"12","author":"Liu","year":"2021","journal-title":"Nat. Commun."},{"key":"10.1016\/j.biomaterials.2022.121936_bib23","doi-asserted-by":"crossref","first-page":"3392","DOI":"10.7150\/thno.52435","article-title":"ILT4 inhibition prevents TAM- and dysfunctional T cell-mediated immunosuppression and enhances the efficacy of anti-PD-L1 therapy in NSCLC with EGFR activation","volume":"11","author":"Chen","year":"2021","journal-title":"Theranostics"},{"key":"10.1016\/j.biomaterials.2022.121936_bib24","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1038\/s41556-020-0461-8","article-title":"Energy stress-mediated AMPK activation inhibits ferroptosis","volume":"22","author":"Lee","year":"2020","journal-title":"Nat. Cell Biol."},{"key":"10.1016\/j.biomaterials.2022.121936_bib25","doi-asserted-by":"crossref","first-page":"4266","DOI":"10.1080\/15548627.2021.1911016","article-title":"Ferritinophagy is involved in the zinc oxide nanoparticles-induced ferroptosis of vascular endothelial cells","volume":"17","author":"Qin","year":"2021","journal-title":"Autophagy"},{"key":"10.1016\/j.biomaterials.2022.121936_bib26","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/j.ccell.2021.12.009","article-title":"MEK inhibition overcomes chemoimmunotherapy resistance by inducing CXCL10 in cancer cells","volume":"40","author":"Limagne","year":"2022","journal-title":"Cancer Cell"},{"key":"10.1016\/j.biomaterials.2022.121936_bib27","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1158\/0008-5472.CAN-21-2362","article-title":"FGFR3 destabilizes PD-L1 via NEDD4 to control T-cell-mediated bladder cancer immune surveillance","volume":"82","author":"Jing","year":"2022","journal-title":"Cancer Res."},{"key":"10.1016\/j.biomaterials.2022.121936_bib28","doi-asserted-by":"crossref","DOI":"10.3390\/ijms222010924","article-title":"Molecular mechanism of food-derived polyphenols on PD-L1 dimerization: a molecular dynamics simulation study","volume":"22","author":"Guo","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.biomaterials.2022.121936_bib29","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1016\/j.pharmthera.2014.09.010","article-title":"Poly(I:C) as cancer vaccine adjuvant: knocking on the door of medical breakthroughs","volume":"146","author":"Ammi","year":"2015","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.biomaterials.2022.121936_bib30","doi-asserted-by":"crossref","DOI":"10.1080\/2162402X.2017.1407899","article-title":"Poly(I:C) primes primary human glioblastoma cells for an immune response invigorated by PD-L1 blockade","volume":"7","author":"De Waele","year":"2018","journal-title":"OncoImmunology"},{"key":"10.1016\/j.biomaterials.2022.121936_bib31","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2020-001156","article-title":"Nuclear imaging-guided PD-L1 blockade therapy increases effectiveness of cancer immunotherapy","volume":"8","author":"Gao","year":"2020","journal-title":"J. Immunother. Cancer."},{"key":"10.1016\/j.biomaterials.2022.121936_bib32","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2020.584626","article-title":"Regulation of PD-L1 expression by NF-\u03baB in cancer","volume":"11","author":"Antonangeli","year":"2020","journal-title":"Front. Immunol."},{"key":"10.1016\/j.biomaterials.2022.121936_bib33","first-page":"14","article-title":"Immune checkpoint regulator PD-L1 expression on tumor cells by contacting CD11b positive bone marrow derived stromal cells, Cell Commun","volume":"13","author":"Noh","year":"2015","journal-title":"Signal"},{"key":"10.1016\/j.biomaterials.2022.121936_bib34","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1038\/s41573-018-0007-y","article-title":"Approaches to treat immune hot, altered and cold tumours with combination immunotherapies","volume":"18","author":"Galon","year":"2019","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.biomaterials.2022.121936_bib35","doi-asserted-by":"crossref","first-page":"e542","DOI":"10.1016\/S1470-2045(16)30406-5","article-title":"Predictive biomarkers for checkpoint inhibitor-based immunotherapy","volume":"17","author":"Gibney","year":"2016","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.biomaterials.2022.121936_bib36","article-title":"Innate immune cells in the tumor microenvironment","volume":"39","author":"Mo","year":"2021","journal-title":"Cancer Cell"},{"key":"10.1016\/j.biomaterials.2022.121936_bib37","article-title":"Dendritic cells in cancer immunology and immunotherapy","volume":"20","author":"Sk","year":"2020","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.biomaterials.2022.121936_bib38","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1038\/s41467-017-00231-1","article-title":"CD206+ M2-like macrophages regulate systemic glucose metabolism by inhibiting proliferation of adipocyte progenitors","volume":"8","author":"Nawaz","year":"2017","journal-title":"Nat. Commun."},{"key":"10.1016\/j.biomaterials.2022.121936_bib39","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aan4488","article-title":"Eradication of spontaneous malignancy by local immunotherapy","volume":"10","author":"Sagiv-Barfi","year":"2018","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.biomaterials.2022.121936_bib40","doi-asserted-by":"crossref","first-page":"330","DOI":"10.3390\/cancers13020330","article-title":"Assessment of cannabidiol and \u03949-tetrahydrocannabiol in mouse models of medulloblastoma and ependymoma","volume":"13","author":"Andradas","year":"2021","journal-title":"Cancers"},{"key":"10.1016\/j.biomaterials.2022.121936_bib41","doi-asserted-by":"crossref","first-page":"3592","DOI":"10.1080\/15548627.2021.1885203","article-title":"Cannabidiol inhibits human glioma by induction of lethal mitophagy through activating TRPV4","volume":"17","author":"Huang","year":"2021","journal-title":"Autophagy"},{"key":"10.1016\/j.biomaterials.2022.121936_bib42","first-page":"1169","article-title":"Cannabidiol induces cell death in human lung cancer cells and cancer stem cells","volume":"14","author":"Hamad","year":"2021","journal-title":"Pharm. Basel Switz."},{"key":"10.1016\/j.biomaterials.2022.121936_bib43","doi-asserted-by":"crossref","first-page":"5733","DOI":"10.1038\/s41467-021-25990-w","article-title":"A nanounit strategy reverses immune suppression of exosomal PD-L1 and is associated with enhanced ferroptosis","volume":"12","author":"Wang","year":"2021","journal-title":"Nat. Commun."},{"key":"10.1016\/j.biomaterials.2022.121936_bib44","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2020-001369","article-title":"Vaccination with early ferroptotic cancer cells induces efficient antitumor immunity","volume":"8","author":"Efimova","year":"2020","journal-title":"J. Immunother. Cancer."},{"key":"10.1016\/j.biomaterials.2022.121936_bib45","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1158\/1535-7163.MCT-10-1100","article-title":"Cannabidiol induces programmed cell death in breast cancer cells by coordinating the cross-talk between apoptosis and autophagy","volume":"10","author":"Shrivastava","year":"2011","journal-title":"Mol. Cancer Therapeut."},{"key":"10.1016\/j.biomaterials.2022.121936_bib46","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41419-019-2001-7","article-title":"Cannabidiol promotes apoptosis via regulation of XIAP\/Smac in gastric cancer","volume":"10","author":"Jeong","year":"2019","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.biomaterials.2022.121936_bib47","doi-asserted-by":"crossref","first-page":"E3203","DOI":"10.3390\/cancers12113203","article-title":"Cannabidiol (CBD) as a promising anti-cancer drug","volume":"12","author":"Seltzer","year":"2020","journal-title":"Cancers"},{"key":"10.1016\/j.biomaterials.2022.121936_bib48","doi-asserted-by":"crossref","first-page":"1359","DOI":"10.1172\/JCI37948","article-title":"Cannabinoid action induces autophagy-mediated cell death through stimulation of ER stress in human glioma cells","volume":"119","author":"Salazar","year":"2009","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.biomaterials.2022.121936_bib49","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1039\/D1NH00506E","article-title":"A self-amplifying nanodrug to manipulate the Janus-faced nature of ferroptosis for tumor therapy","volume":"7","author":"Zhang","year":"2022","journal-title":"Nanoscale Horiz"},{"key":"10.1016\/j.biomaterials.2022.121936_bib50","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1038\/s41422-020-00441-1","article-title":"Ferroptosis: molecular mechanisms and health implications","volume":"31","author":"Tang","year":"2021","journal-title":"Cell Res."},{"key":"10.1016\/j.biomaterials.2022.121936_bib51","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.canlet.2015.02.027","article-title":"TLR3 triggering regulates PD-L1 (CD274) expression in human neuroblastoma cells","volume":"361","author":"Boes","year":"2015","journal-title":"Cancer Lett."},{"key":"10.1016\/j.biomaterials.2022.121936_bib52","doi-asserted-by":"crossref","first-page":"3737","DOI":"10.1158\/0008-5472.CAN-19-0596","article-title":"Low-dose IFN\u03b3 induces tumor cell stemness in tumor microenvironment of non-small cell lung cancer","volume":"79","author":"Song","year":"2019","journal-title":"Cancer Res."},{"key":"10.1016\/j.biomaterials.2022.121936_bib53","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1002\/ijc.31357","article-title":"IFN-\u03b3-mediated inhibition of lung cancer correlates with PD-L1 expression and is regulated by PI3K-AKT signaling","volume":"143","author":"Gao","year":"2018","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.biomaterials.2022.121936_bib54","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1038\/s41423-021-00735-3","article-title":"IFN\u03b3 signaling integrity in colorectal cancer immunity and immunotherapy","volume":"19","author":"Du","year":"2022","journal-title":"Cell. Mol. Immunol."},{"key":"10.1016\/j.biomaterials.2022.121936_bib55","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1016\/j.actbio.2021.07.055","article-title":"In Situ biomimetic Nanoformulation for metastatic cancer immunotherapy","volume":"134","author":"Zhang","year":"2021","journal-title":"Acta Biomater."},{"key":"10.1016\/j.biomaterials.2022.121936_bib56","doi-asserted-by":"crossref","first-page":"1565","DOI":"10.1126\/science.1203486","article-title":"Cancer immunoediting: integrating immunity's roles in cancer suppression and promotion","volume":"331","author":"Schreiber","year":"2011","journal-title":"Science"},{"key":"10.1016\/j.biomaterials.2022.121936_bib57","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1016\/j.bbrc.2019.01.090","article-title":"The release and activity of HMGB1 in ferroptosis","volume":"510","author":"Wen","year":"2019","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.biomaterials.2022.121936_bib58","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1089\/can.2018.0073","article-title":"Immune responses regulated by cannabidiol","volume":"5","author":"Nichols","year":"2020","journal-title":"Cannabis Cannabinoid Res"},{"key":"10.1016\/j.biomaterials.2022.121936_bib59","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.pharmthera.2017.02.041","article-title":"Cannabidiol: state of the art and new challenges for therapeutic applications","volume":"175","author":"Pisanti","year":"2017","journal-title":"Pharmacol. Ther."}],"container-title":["Biomaterials"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0142961222005762?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0142961222005762?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,26]],"date-time":"2025-09-26T17:15:15Z","timestamp":1758906915000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0142961222005762"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,1]]},"references-count":59,"alternative-id":["S0142961222005762"],"URL":"https:\/\/doi.org\/10.1016\/j.biomaterials.2022.121936","relation":{},"ISSN":["0142-9612"],"issn-type":[{"value":"0142-9612","type":"print"}],"subject":[],"published":{"date-parts":[[2023,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A nanoformulation for immunosuppression reversal and broad-spectrum self-amplifying antitumor ferroptosis-immunotherapy","name":"articletitle","label":"Article Title"},{"value":"Biomaterials","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biomaterials.2022.121936","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"121936"}}